Publication: Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation
Issued Date
2018-12-20
Resource Type
ISSN
18733476
03785173
03785173
Other identifier(s)
2-s2.0-85055143493
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Pharmaceutics. Vol.553, No.1-2 (2018), 157-168
Suggested Citation
Napaphak Jaipakdee, Ekapol Limpongsa, Bung orn Sripanidkulchai, Pawinee Piyachaturawat Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation. International Journal of Pharmaceutics. Vol.553, No.1-2 (2018), 157-168. doi:10.1016/j.ijpharm.2018.10.031 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/47289
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation
Other Contributor(s)
Abstract
© 2018 Elsevier B.V. Curcuma comosa (C. comosa) is a Thai medicinal herb that provides numerous pharmacologic activities due to its estrogen-like action. This study aimed to investigate the use of liquisolid technique to prepare tablets containing oleoresin-like crude extract of C. comosa, and to improve the dissolution profiles of its major compounds, diarylheptanoids (DAs). Free flowing powders of C. comosa extract were obtained by adsorption onto solid carriers, microcrystalline cellulose, with colloidal silica as coating material. FTIR results ruled out possible interactions between C. comosa extract and excipients. The results indicated that all of liquisolid tablets met the USP requirements. The release of DAs were significantly increased through liquisolid formulations, compared to crude extract. By decreasing the ratio of carrier to coating from 20 to 10, an improvement in dissolution rate was observed. Addition of additives - namely polymer (polyvinyl pyrrolidone) and/or nonvolatile liquid (propylene glycol) affected tablet properties which involved longer disintegration time and lower DA dissolution. Optimized C. comosa liquisolid formulation was prepared in a carrier to coating ratio of 10 without additives. Stability studies showed that physical properties of liquisolid tablet were not affected by aging, but percent remaining and dissolution profiles of DAs were influenced by storage temperature. In vivo pharmacokinetic behavior of the optimized C. comosa liquisolid tablets was investigated following a single oral administration to rabbits. The results proved that the method used for preparation of liquisolid led to C. comosa tablets with low variation in content uniformity and tablet properties, as well as enhanced dissolution behavior.